- Trials with a EudraCT protocol (77)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
77 result(s) found for: Regeneration.
Displaying page 1 of 4.
| EudraCT Number: 2020-001939-27 | Sponsor Protocol Number: SystABSinus01 | Start Date*: 2021-02-25 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
| Full Title: The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with guided bone regeneration and simultaneous sinus floor ele... | ||
| Medical condition: patients undergoing oral implant therapy with simultaneous lateral sinus floor elevation and guided bone regeneration (GBR) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019380-11 | Sponsor Protocol Number: 09/0278 | Start Date*: 2010-09-30 |
| Sponsor Name: | ||
| Full Title: Autologous cell therapy of fracture non-union – cell phenotype as a predictor of outcome | ||
| Medical condition: delayed fracture union (fracture non-union) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001811-56 | Sponsor Protocol Number: Syst.Antibiotics&GBR | Start Date*: 2014-09-26 |
| Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Zahn-, Mund- und Kieferheilkunde | ||
| Full Title: The effect of systemic antibiotics on clinical and patient-centered outcomes of implant therapy and simultaneous guided bone regeneration. A randomised controlled clinical trial. | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-003409-98 | Sponsor Protocol Number: HERA-05/001 | Start Date*: 2006-02-09 |
| Sponsor Name:Hôpital Erasme, Cliniques Universitaires de Bruxelles | ||
| Full Title: Enhancement by tacrolimus of nerve regeneration after peripheral nerve repair. | ||
| Medical condition: Patients presenting a total section of a major nerve at the arm, forearm, or leg, and treated by conventional nerve suture under microscope within ten days of the trauma. Patients with nerve autogr... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-005374-26 | Sponsor Protocol Number: ECAELEV21 | Start Date*: 2022-08-18 |
| Sponsor Name:OMEQUI coordinator | ||
| Full Title: Efficacy of platelet- and leukocyte-rich fibrin (L-PRF) in reducing healing time in sinus lift combined with deproteinized bovine mineralized bone (DBBM): randomized clinical trial. | ||
| Medical condition: If the application of L-PRF with respect to the use of DBBM shows that there are differences in the percentage of new bone between the LPRF group and the control group at 4 and 6 months | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001885-14 | Sponsor Protocol Number: HN010/HTF-003 | Start Date*: 2005-08-24 |
| Sponsor Name:Henogen s.a. | ||
| Full Title: A phase II, randomised, double blind, matched pair, controlled study to assess the safety and efficacy of Henogen recombinant soluble human tissue factor (rshTF) on the mandible bone consolidation... | ||
| Medical condition: Orthognathic surgery, cases of Bilateral Sagittal Split Osteotomy (B.S.S.O) of the mandible to achieve facial and occlusal balance. This could create bone gaps or continuity defects. These bone gap... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004644-28 | Sponsor Protocol Number: 13-129 | Start Date*: Information not available in EudraCT |
| Sponsor Name:RWTH Aachen University, represented by the Rector, himself, represented by the Dean of the Medical Faculty | ||
| Full Title: Administration of Rifaximin to improve Liver Regeneration and Outcome following Major Liver Resection | ||
| Medical condition: Patients undergoing major liver resection will be included into the study | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-003934-16 | Sponsor Protocol Number: 1301-01 | Start Date*: 2012-08-01 | |||||||||||
| Sponsor Name:Pluristem Ltd. | |||||||||||||
| Full Title: A Phase I/II, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Regeneration of Injured Gluteal Mu... | |||||||||||||
| Medical condition: Regeneration of injured Gluteal Musculature (GM) after Total Hip Arthroplasty (THA) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-004684-40 | Sponsor Protocol Number: N-O_CLI_Study | Start Date*: 2018-04-19 | |||||||||||
| Sponsor Name:Krakowski Szpital Specjalistyczny im. Jana Pawła II | |||||||||||||
| Full Title: Regeneration of ischemic damages in cardiovascular system using Wharton’s jelly as an unlimited source of mesenchymal stem cells for regenerative medicine. Project of the National Centre for Resear... | |||||||||||||
| Medical condition: Critical limb ischemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: PL (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-004662-25 | Sponsor Protocol Number: AMI-Study | Start Date*: 2017-10-18 | |||||||||||
| Sponsor Name:Krakowski Szpital Specjalistyczny im. Jana Pawła II | |||||||||||||
| Full Title: Regeneration of ischemic damages in cardiovascular system using Wharton’s jelly as an unlimited source of mesenchymal stem cells for regenerative medicine. Project of the National Centre for Resear... | |||||||||||||
| Medical condition: AMI: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-005883-25 | Sponsor Protocol Number: Scil-MD05-C02 | Start Date*: 2007-04-25 | |||||||||||
| Sponsor Name:Scil Technology GmbH | |||||||||||||
| Full Title: Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison with Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects | |||||||||||||
| Medical condition: | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-007022-64 | Sponsor Protocol Number: NMSG 16/07 | Start Date*: 2007-03-06 |
| Sponsor Name:Rigshospitalet | ||
| Full Title: Phase II study of bortezomib-dexametason and high-dose melphalan in patients relapsing after high-dose melphalan with autologous stem cell support | ||
| Medical condition: Patients with multiple myeloma earlier treated with high-dose melphalan with autologous stem cell support experiencing their first relapse. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DK (Ongoing) SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-003537-25 | Sponsor Protocol Number: 04032008 | Start Date*: 2008-08-28 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Can the steady-state hematopoiesis be improved post-ASCT by infusion of the autologous stem cell transplant directly in the bone marrow compartment. | ||
| Medical condition: Study population - patient age 18-65 years - eligible for an ASCT for lymphoma or MM - at least ≥ 10 x 106 CD34+ cells/kg have been collected during the previous performed leucofereses procedure | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-001375-11 | Sponsor Protocol Number: not applicable | Start Date*: 2007-05-16 |
| Sponsor Name: | ||
| Full Title: Effects and health economic aspects of enzyme therapy in children and adults with Pompe disease Long-term follow-up of patients receiving commercially available Myozyme | ||
| Medical condition: Pompe disease (glycogen storage disease type II) is a genetic, lysosomal storage disorder with a frequency of 1 in 40.000 newborns. The disease is caused by deficiency of alpha-glucosidase, a lysos... | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-007694-23 | Sponsor Protocol Number: 593 | Start Date*: 2008-07-28 |
| Sponsor Name:Forschergruppe Diabetes e. V. | ||
| Full Title: Transfusion of Autologous Umbilical Cord Blood to Reverse Hyperglycemia in Children with Type 1 Diabetes - A Pilot Study | ||
| Medical condition: Type 1 Diabetes | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-006238-87 | Sponsor Protocol Number: 4717 | Start Date*: 2010-01-22 |
| Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
| Full Title: Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K | ||
| Medical condition: Patients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolism | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-004625-42 | Sponsor Protocol Number: KardioPII | Start Date*: 2009-01-09 |
| Sponsor Name:Asklepios Kliniken Hamburg GmbH | ||
| Full Title: Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction using Bone Marrow Mononuclear Cells | ||
| Medical condition: Acute myocardial infarction (LVEF<45%) ICD10: I21.9 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003551-20 | Sponsor Protocol Number: 2006-MSC-01 | Start Date*: 2007-06-25 |
| Sponsor Name:Department of Oral Surgery Dental School Med. Univ. Graz, Austria | ||
| Full Title: The Effect of adult MSC on Bone Regeneration and Osseointegration of Dental Implants following a Sinus Augmentation Procedure | ||
| Medical condition: In patients with biltareral edentulous areas and resorbed alveolar processes in the maxilla a bilateral sinus augmentation with Bio-OssTM, CE certified (Geistlich Biomaterials, Wolhusen Switzerlan... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005709-50 | Sponsor Protocol Number: 1122005 | Start Date*: 2006-05-05 |
| Sponsor Name:Cardiology, University of Frankfurt | ||
| Full Title: Extracorporal shock wave therapy for induction of therapeutic neovascularization and homing of bone marrow progenitor cells in patients with chronic ischemic heart disease | ||
| Medical condition: Patients with ischemic coronary artery disease (congestive heart failure) and s/p anterior myocardial infarction | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-004779-36 | Sponsor Protocol Number: BMTI-2006-03-EU | Start Date*: 2007-01-22 | |||||||||||
| Sponsor Name:BioMimetic Therapeutic Inc | |||||||||||||
| Full Title: A Human Clinical Trial to Evaluate the Safety and Clinical Utility of GEM OS1 as a Bone Regeneration System in Foot and Ankle Arthrodesis Procedures | |||||||||||||
| Medical condition: For use as a bone void filler for voids or gaps that are not intrinsic to the stability of bony structure. Treatment of surgically created osseous defects or osseous defects resulting from patholo... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) FR (Completed) AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
